Affitech developes R84 in partnership with US Peregrine Pharmaceutical John Erik Stacy Affitech is one of the hot new biotech companies to be hatched out of the incubator at Oslo Research Park. The name comes from AFFInity TECHnology and reflects a focus on developing drugs that have affinity for specific cell types, in particular cancers. […]
Affitech developes R84 in partnership with US Peregrine Pharmaceutical John Erik Stacy Affitech is one of the hot new biotech companies to be hatched out of the incubator at Oslo Research Park. The name comes from AFFInity TECHnology and reflects a focus on developing drugs that have affinity for specific cell types, in particular cancers. […]